Eric Didillon

Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum

C. Rogier, B. Pradines, N. Bourgeois, 2012, Malaria Journal.

Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum

S. Briolant, C. Rogier, B. Pradines, 2010, Malaria Journal.

Absence of Association between Piperaquine In Vitro Responses and Polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe Genes in Plasmodium falciparum

S. Briolant, C. Rogier, B. Pradines, 2010, Antimicrobial Agents and Chemotherapy.

Absence of Association between Piperaquine In Vitro Responses and Polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe Genes in Plasmodium falciparum

S. Briolant, C. Rogier, B. Pradines, 2010, Antimicrobial Agents and Chemotherapy.

Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum

C. Rogier, B. Pradines, D. Malvy, 2012, Malaria Journal.